The Committee adopted the CHMP recommendation and scientific discussion, together with a list of questions for the applicant. (European Medicines Agency) - Aug 30, 2026 - CHMP Final
Minutes of the meeting on 23 - 26 Feb 2026: CHMP discussed the issues identified in the application for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults.
CHMP • Hidradenitis Suppurativa • Immunology
|